Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center

BACKGROUND: Immune checkpoint inhibitors (ICIs) are a novel class of anticancer agents that have demonstrated clinical response for both solid and hematological malignancies. ICIs are associated with development of immune-related adverse events including cardiotoxicity. We estimated the incidence of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiooncology
Main Authors: Waheed, Nida, Fradley, Michael G., DeRemer, David L., Mahmoud, Ahmad, Shah, Chintan P., Langaee, Taimour Y., Lipori, Gloria P., March, Keith, Pepine, Carl J., Cooper-DeHoff, Rhonda M., Wu, Yonghui, Gong, Yan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977591/
https://ncbi.nlm.nih.gov/pubmed/33736707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-021-00097-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados